|
SPORE in Lymphoma
|
3P50CA126752-10S1
|
$300,703
|
$105,246
|
HESLOP, HELEN
|
BAYLOR COLLEGE OF MEDICINE
|
|
SPORE in Lymphoma
|
4P50CA126752-10
|
$2,344,258
|
$820,490
|
HESLOP, HELEN
|
BAYLOR COLLEGE OF MEDICINE
|
|
Cancer Center Support Grant
|
3P30CA033572-33S1
|
$125,651
|
$1,257
|
ROSEN, STEVEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Cancer Center Support Grant
|
3P30CA033572-33S2
|
$124,999
|
$1,250
|
ROSEN, STEVEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Cancer Center Support Grant
|
3P30CA033572-33S3
|
$37,400
|
$374
|
ROSEN, STEVEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Cancer Center Support Grant
|
3P30CA033572-33S4
|
$350,000
|
$3,500
|
ROSEN, STEVEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Cancer Center Support Grant
|
4P30CA033572-33
|
$2,520,000
|
$25,200
|
ROSEN, STEVEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Novel AHCT Regimen for Advanced Hodgkin Lymphoma using Y-90 anti-CD25 with BEAM
|
5R21CA185875-02
|
$174,122
|
$174,122
|
SMITH, EILEEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Epstein-Barr Virus Nuclear Protein in B Cell Growth Transformation
|
4R01CA047006-29
|
$565,231
|
$282,616
|
KIEFF, ELLIOTT
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Epstein-Barr Virus LMP1-Mediated Oncogenecity
|
4R01CA085180-15
|
$762,316
|
$381,158
|
KIEFF, ELLIOTT
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Roles of Epstein-Barr virus nuclear antigens 2 and LP in B cell proliferation
|
4R01CA170023-04
|
$393,163
|
$196,582
|
KIEFF, ELLIOTT
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
COG NCTN Network Group Operations Center
|
3U10CA180886-03S1
|
$3,025,319
|
$121,013
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
COG NCTN Network Group Operations Center
|
5U10CA180886-03
|
$21,084,883
|
$843,395
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
Cancer Center Support Grant
|
3P30CA013696-42S1
|
$120,000
|
$1,200
|
EMERSON, STEPHEN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA013696-42S2
|
$60,000
|
$600
|
EMERSON, STEPHEN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA013696-42S3
|
$121,873
|
$1,219
|
EMERSON, STEPHEN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA013696-42S4
|
$150,866
|
$1,509
|
EMERSON, STEPHEN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA013696-42S5
|
$199,541
|
$1,995
|
EMERSON, STEPHEN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA013696-42S6
|
$500,000
|
$5,000
|
EMERSON, STEPHEN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
5P30CA013696-42
|
$3,792,720
|
$37,927
|
EMERSON, STEPHEN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
The Role of NF-kB in B-Cell Differentiation and Lymphomagenesis
|
4R01CA157660-05
|
$331,433
|
$165,717
|
KLEIN, ULF
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA006516-51S1
|
$122,500
|
$1,225
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support Grant
|
3P30CA006516-51S2
|
$37,500
|
$375
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support Grant
|
3P30CA006516-51S3
|
$125,000
|
$1,250
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support Grant
|
3P30CA006516-51S4
|
$200,000
|
$2,000
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support Grant
|
3P30CA006516-51S5
|
$60,000
|
$600
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support Grant
|
3P30CA006516-51S6
|
$199,953
|
$2,000
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support Grant
|
3P30CA006516-51S7
|
$500,000
|
$5,000
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support Grant
|
3P30CA006516-51S8
|
$750,000
|
$7,500
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support Grant
|
4P30CA006516-51
|
$11,151,311
|
$111,513
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Targetable Immune Evasion Pathways in Hodgkin Lymphoma
|
2R01CA161026-06
|
$410,899
|
$205,450
|
SHIPP, MARGARET
|
DANA-FARBER CANCER INST
|
|
Adult Leukemia Research Center
|
4P01CA018029-41
|
$4,225,448
|
$380,290
|
APPELBAUM, FREDERICK
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Optimal Antiretroviral Therapy During Bone Marrow Transplant in HIV-1 Infection
|
5K23CA177321-03
|
$161,608
|
$64,643
|
DURAND, CHRISTINE
|
JOHNS HOPKINS UNIVERSITY
|
|
SEVERABLE FUNDING FOR NCI-FREDERICK
|
261200800001E
|
$248,730,791
|
$4,463
|
UNKNOWN, UNKNOWN
|
LEIDOS BIOMEDICAL RESEARCH, INC.
|
|
Smartphone for molecular cancer diagnostic in Africa
|
1UH2CA202637-01
|
$491,375
|
$245,688
|
WEISSLEDER, RALPH
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Research Management and Support
|
RMS ES 2016
|
$320,501,735
|
$20,000
|
N/A
|
National Institutes of Health
|
|
Anatomic Pathology Residency Program
|
ZIE BC 011384
|
$1,014,935
|
$20,299
|
Barr, Frederic
|
CCR (NCI)
|
|
Medical Oncology Fellowship Program
|
ZIE BC 010843
|
$4,305,516
|
$215,276
|
Bilusic, Marijo
|
CCR (NCI)
|
|
Radiation Oncology Branch - Radiation Clinic
|
ZID BC 010990
|
$5,116,524
|
$409,322
|
Camphausen, Kevin
|
CCR (NCI)
|
|
CLL Families-Mayo
|
ZIA CP004410-10312
|
$20,918
|
$1,046
|
Caporaso, Neil
|
DCEG (NCI)
|
|
CCR Genomics Core
|
ZIC BC 011623
|
$854,010
|
$85,401
|
Conner, Elizabeth
|
CCR (NCI)
|
|
Dermatology Consultation Service
|
ZID BC 011317
|
$362,445
|
$108,734
|
Cowen, Edward
|
CCR (NCI)
|
|
Basic and Preclinical Animal Models in support of Cancer and HIV-AIDS Research
|
ZIG BC 010856
|
$14,732,997
|
$736,650
|
Custer, Mary
|
CCR (NCI)
|
|
HIV AIDS cancer match, U.S.
|
ZIA CP010150-10071
|
$196,073
|
$29,411
|
Engels, Eric
|
DCEG (NCI)
|
|
Registry linkage projects [including Scandinavia, SEER Medicare, other]
|
ZIA CP010150-10359
|
$17,803
|
$3,561
|
Engels, Eric
|
DCEG (NCI)
|
|
Cancer risk in solid organ transplant recipients and endstage renal disease
|
ZIA CP010150-10362
|
$240,777
|
$12,039
|
Engels, Eric
|
DCEG (NCI)
|
|
Pharmacokinetic and Pharmacodynamic Modeling of Anticancer Agents
|
ZIC BC 010548
|
$345,321
|
$69,064
|
Figg, William
|
CCR (NCI)
|
|
Understanding T Cell Rapamycin Resistance
|
ZIA BC 011220
|
$252,285
|
$25,229
|
Fowler, Daniel
|
CCR (NCI)
|
|
Natural History Study of the Complications Associated with Allogeneic HCT
|
ZIA BC 011742
|
$369,153
|
$29,532
|
Gea-Banacloche, Juan
|
CCR (NCI)
|
|
Hodgkin's families
|
ZIA CP004410-08167
|
$30,637
|
$29,105
|
Goldin, Lynn
|
DCEG (NCI)
|
Total relevant funding to Hodgkins disease for this search: $12,769,043
|